ophthalmology-congress-2016_scientifictracks-abstracts

5 / 32

Notes:
Page 24
Ophthalmology Congress 2016
December 05-06, 2016
Volume 7 Issue 11(Suppl) J Clin Exp Ophthalmol
ISSN: 2155-9570 JCEO, an open access journal
conferenceseries .com
December 05-06, 2016 Madrid, Spain
7th European Ophthalmology Congress
Georgii Kliuiev, J Clin Exp Ophthalmol 2016, 7:11(Suppl)
Micropulse laser transscleral contact-compression cyclocoagulation in the treatment of patients
with refractory glaucoma
Georgii Kliuiev
The Health Technology Ltd, Ukraine
The method of micropulse transscleral contact-compression diode laser cyclocoagulation (MTCCLCC) is considered to
be safe and rather effective method of treatment for lowering intraocular pressure (IOP) in glaucoma. Especially it is
very important for patients that act as resistant to medical and surgical treatment. In recent years, MTCCLCC is becoming a
more common procedure as an alternative to surgical interventions for refractory glaucoma, which is difficult to treat. In this
context, the aim of our study is to evaluate the effectiveness of our methodology of MTCCLCC in the treatment of patients
with refractory glaucoma. To assess the effectiveness of MTCCLCC in 84 patients (88 eyes) with refractory glaucoma, it was
researched IOP before and after treatment. The patient’s condition was observed up to three years. MTCCLCC have been
repeated if the IOP was not adequate after one month of observation. Data are presented as M±m. For data analysis, paired
Wilcoxon test with SPSS 10 was used. Before applying MTCCLCC to patients with refractory glaucoma, IOP was in the range
of 18-58 mm Hg on maximum medical therapy. The average value of the group was 33.05 mm Hg. There was a significant
reduction already after one day of observation among patients after the one-time treatment of MTCCLCC. These patients had
the IOP 24.07±2.06 mm Hg which accounted 72.8% compared with the original data (33.05±1.13 mm Hg). In the average
period of observation (7-10 days) was noted a steady decrease of IOP and it was 22.19±1.99 mm Hg 67.1% compared to the
original data. After treatment, the IOP of patients was significantly reduced to 20.89±1.78 mm Hg which accounted for 63.2%
compared with the original data. The obtained data confirm high efficiency of treatment of patients with refractory glaucoma
by using our techniques of micropulse transscleral contact-compression diode laser cyclocoagulation (MTCCLCC).
Biography
Georgii Kliuiev has completed his specialty in Medical Treatment at Odessa Medical Institute named by N I Pirogov in 1982. From 1982-1988, he has worked as
an Ophthalmology Surgeon at Filatov Eye Disease and Tissue Therapy Institute of Odessa. He has completed his Doctor of Medicine in 1992. He is the Chief of
Ophthalmology Department in Health Technology Ltd. In 2015, he has obtained certificate in Child Ophthalmology. He has published 52 scientific publications and
has five patents. He has 35 years of varied experience in ophthalmic surgery.